Tianlong Luo
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Metabolic CRISPR screening identifies RPE as a key regulator of acquired enzalutamide resistance through FKBP5 destabilization in prostate cancer.
Journal: Oncogene
Published: May 02, 2026
Butyrylated PGAM5-Triggered and GSH-Responsive Cysteine Polymer Nanoparticles for CBL0137 Delivery to Enhance Necroptosis in Prostate Cancer.
Journal: Advanced healthcare materials
Published: March 03, 2026
ANXA2-mediated Phagocytosis Generates AR+ Macrophages to Confer Enzalutamide Resistance in Prostate Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 02, 2025
Erratum to "Integrative analysis of cuproptosis-related lncRNAs: Unveiling prognostic significance, immune microenvironment, and copper-induced mechanisms in prostate cancer" [Cancer Pathog Ther , 3 (2025):48-59].
Journal: Cancer pathogenesis and therapy
Published: June 03, 2025
Induction of ferroptosis in prostate cancer by CCDC719-13 via TRIM21-mediated ubiquitination of SLC7A11.
Journal: Cell death and differentiation
Published: May 25, 2025
A novel polypeptide encoded by circSPIRE1 promotes prostate cancer proliferation and migration by restraining the ubiquitin-dependent degradation of LRP5.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 02, 2025
Regulation of macrophage plasticity by circCCDC7 19-13 through HSP90 inhibition suppresses prostate cancer progression and metastasis: a translational study.
Journal: International journal of surgery (London, England)
Published: March 05, 2025
Correction: Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the JAK1/STAT4 pathway.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 28, 2024
FOXA1-dependent PUS1 regulates EIF3b stability in a non-enzymatic pathway mediating prostate cancer bone metastasis.
Journal: International journal of biological sciences
Published: July 13, 2024
Evaluating the effectiveness of cytoreductive surgery in oligometastatic prostate cancer: insights from quantitative analysis and retrospective cohort studies.
Journal: International journal of surgery (London, England)
Published: May 21, 2024
Predicting Survival in Patients with Neuroendocrine Prostate Cancer: A SEER-Based Comprehensive Study.
Journal: The world journal of men's health
Published: March 07, 2024
Last Updated: 09/26/2026